This biotech CEO believes that GLP-1s will eventually be replaced by a different class of medicines as the go-to weight loss drugs
- Nov 22, 2025
- 1 min read
Zealand's Adam Steensberg makes the case for Amylins
Coverage brought to you by
top of page
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.
Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.
bottom of page